Who owns Mereo Biopharma Group Plc ads?
- Ticker: MREO
- CUSIP Number: 589492107
Tip: Access positions for across all investors
Analyze quarterly positions in Mereo Biopharma Group Plc ads with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mereo Biopharma Group Plc ads stock
Who bought or sold Mereo Biopharma Group Plc ads this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Soleus Capital Management | 9.8M | $23M | 1% | Dec 2023 |
|
| 683 Capital Management | 6.2M | $14M | 3% | Dec 2023 |
|
| Tejara Capital | 3.7M | $8.6M | 15% | Dec 2023 |
|
| Clearline Capital | 3.3M | $7.7M | 7% | Dec 2023 |
|
| Goldman Sachs Group | 2.0M | $4.7M | 0% | Dec 2023 |
|
| Standard Life Aberdeen | 1.6M | $3.6M | 100% | Dec 2023 |
|
| Millennium Management | 1.4M | $3.3M | 13% | Dec 2023 |
|
| DAFNA Capital Management | 779k | $1.8M | -19% | Dec 2023 |
|
| Monaco Asset Management SAM | 677k | $1.6M | 14% | Dec 2023 |
|
| Citadel Advisors | 350k | $808k | -84% | Dec 2023 |
|
| Toroso Investments | 319k | $738k | -4% | Dec 2023 |
|
| Two Sigma Investments | 311k | $719k | 118% | Dec 2023 |
|
| Squarepoint Ops | 258k | $595k | 100% | Dec 2023 |
|
| J. Goldman & Co | 162k | $374k | -64% | Dec 2023 |
|
| Knoll Capital Management | 161k | $370k | 100% | Dec 2023 |
|
| Fred Alger Management | 103k | $237k | 100% | Dec 2023 |
|
| Clear Harbor Asset Management | 60k | $108k | -6% | Dec 2023 |
|
| Hsbc Holdings | 58k | $135k | 0% | Dec 2023 |
|
| PRIMECAP Management Company | 54k | $125k | -32% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 50k | $116k | -62% | Dec 2023 |
|
| PFG Investments | 31k | $103k | 4% | Mar 2024 |
|
| Centiva Capital | 25k | $58k | 0% | Dec 2023 |
|
| Lynwood Capital Management | 25k | $58k | 100% | Dec 2023 |
|
| Virtu Financial | 20k | $47k | -40% | Dec 2023 |
|
| Golden State Equity Partners | 20k | $47k | 41% | Dec 2023 |
|
| Level Four Advisory Services | 20k | $46k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 19k | $44k | -86% | Dec 2023 |
|
| Marshall Wace | 15k | $34k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 15k | $34k | 100% | Dec 2023 |
|
| Total Clarity Wealth Management | 12k | $39k | 100% | Mar 2024 |
|
| Newbridge Financial Services Group | 9.5k | $22k | 100% | Dec 2023 |
|
| GAMMA Investing | 6.0k | $20k | 30% | Mar 2024 |
|
| SRS Capital Advisors | 4.0k | $9.2k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 3.9k | $9.0k | 9% | Dec 2023 |
|
| UBS Group | 2.8k | $6.5k | 100% | Dec 2023 |
|
| Hanson McClain Advisors | 1.5k | $3.5k | 0% | Dec 2023 |
|
| BFSG | 1.0k | $3.3k | 100% | Mar 2024 |
|
| New England Capital Financial Advisors | 300.00 | $693.000000 | 0% | Dec 2023 |
|
| Bank of America Corporation | 276.00 | $638.001600 | -97% | Dec 2023 |
|
| Wells Fargo & Company | 230.00 | $529.989000 | 0% | Dec 2023 |
|
| Highlander Capital Management | 127.00 | $293.001700 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 57.00 | $0 | 100% | Dec 2023 |
|
| Plante Moran Financial Advisors | 48.00 | $111.000000 | 0% | Dec 2023 |
|
| Barclays | 38.00 | $0 | -50% | Dec 2023 |
|
| Us Bancorp | 13.00 | $30.000100 | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $6.999900 | 0% | Dec 2023 |
|
Who sold out of Mereo Biopharma Group Plc ads?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ikarian Capital | Sep 2023 | 592k | $191k |
| BBK Capital Partners | Sep 2023 | 332k | $428k |
| Jane Street | Sep 2023 | 17k | $22k |
| Creative Planning | Sep 2023 | 16k | $20k |
| Spire Wealth Management | Dec 2023 | 250.00 | $789.000000 |